Midi Health is a virtual clinic for perimenopause and menopause that does something most menopause telehealth does not: it bills your insurance. Where the category standard is a monthly subscription and a cash-pay prescription, Midi runs as a clinical practice, in-network with most PPO plans, in all 50 states.
That single design choice drives everything else about the platform, including the parts that frustrate people. Visits are real appointments rather than questionnaires. Labs can be ordered. And the price you will actually pay cannot be quoted in advance, because it depends on a plan Midi does not control.
The Verdict
Is Midi Health Legit?
Yes, Midi Health is a legitimate telehealth company, founded in 2021 and based in Palo Alto, California, with Joanna Strober as co-founder and chief executive. Midi announced a $100 million Series D funding round in February 2026 at a valuation exceeding $1 billion. Its announced rounds add up to about $250 million. It operates across all 50 states.
Under Midi's published Terms and Conditions, Midi Health, Inc. is not a healthcare provider itself. Care is delivered through affiliated medical practices, including Integrative Women's Care PC, that employ or contract with medical doctors, nurse practitioners, and clinicians holding Menopause Society credentials. Midi's pricing and insurance page says it is in-network with most PPO plans and names Aetna, Blue Cross Blue Shield, Cigna, Health Net and UnitedHealthcare. Medicare is out of network, and Midi cannot accept Medicaid.
Clinicians prescribe hormone replacement therapy, non-hormonal treatments, and glucagon-like peptide-1 (GLP-1) medications. Midi's terms also name a compounding pharmacy, Precision Compounding Pharmacy, for some prescriptions. Its weight programs can include compounded GLP-1 drugs, and it offers topical compounded testosterone for women in 25 states. Compounded drugs are not approved by the Food and Drug Administration (FDA), which Midi notes on its site.
As of October 2, 2026, Midi holds a B rating with the Better Business Bureau (BBB), with accreditation since March 2024 and 176 closed complaints over three years. On Trustpilot, Midi has a TrustScore of 4.1 out of 5 across 1,691 reviews as of October 2, 2026.
Two federal civil lawsuits filed against Midi in California were both voluntarily dismissed with no decision on the merits, as detailed in the Public litigation section below. In addition, Midi's published terms require resolving disputes through binding individual arbitration unless you opt out.
Scorecard
| Category | Score | Why |
|---|---|---|
| Cost transparency | 6/10 | Self-pay rates are published; insured cost depends entirely on your plan |
| Clinician access | 8/10 | 30-minute first visit and 15-minute follow-ups with midlife-specialist clinicians |
| Testing depth | 7/10 | Labs ordered when indicated rather than as a standard panel; billed separately |
| Prescription pathway | 8/10 | Hormone and non-hormone options, vaginal estrogen and GLP-1s; Midi's terms also name a compounding pharmacy for some prescriptions |
| Insurance handling | 9/10 | In-network with most PPO plans (five named national insurers); service available in all 50 states |
What you get for the money
A Midi first visit runs 30 minutes. The clinician works through symptoms, health history and goals, then builds a care plan. Follow-ups run 15 minutes and exist to track what is working and adjust what is not, and Midi states you can book them as often as you need rather than on a fixed schedule.
Care plans can include hormone prescriptions such as HRT patches, estradiol cream and progesterone, vaginal estrogen for genitourinary symptoms, non-hormone prescriptions, and GLP-1 medications. Some products can be handled through a short asynchronous visit; others require the full appointment. Midi also sells supplements and a skincare product directly, which are optional and separate from the clinical relationship.
Testing is available but not automatic. Midi states it may order labs to understand the full picture, naming a metabolic panel, thyroid testing and insulin-sensitivity markers. Bloodwork generally goes through Labcorp because of its drop-in network, and can be ordered elsewhere on request. Labs are billed separately from the visit.
What it costs
| Line item | Cost | What it covers |
|---|---|---|
| First visit, self-pay | $250 | 30 minutes with a clinician covering symptoms, health history and goals, ending in a care plan. |
| Returning visit, self-pay | $150 | 15-minute check-in to track progress and adjust the plan. |
| First visit, in-network | Plan copay or coinsurance | Billed to the plan. Deductible, coinsurance and copay all vary, so the amount is plan-specific. |
| Membership or subscription | None | Midi states there are no hidden subscription fees; you pay per visit. |
| Labs | Billed separately | Ordered when indicated. Midi notes additional cost may apply and generally uses Labcorp. |
| Prescriptions | Billed by your pharmacy | Most prescriptions go to the pharmacy of your choice; some compounded products are filled by Precision Compounding Pharmacy. |
Self-pay is the only path with a knowable total. Two visits in a year, one initial and one follow-up, cost $400. Three visits cost $550. There is no membership fee layered on top, which distinguishes Midi from most of the category.
The insured path is cheaper for most people who qualify and genuinely unpredictable for all of them. An in-network PPO visit against a met deductible can cost a standard specialist copay. The same visit early in a plan year, against an unmet deductible, can cost the full contracted rate. Midi is explicit that deductibles, coinsurance and copays vary and may still apply, which is accurate rather than evasive, but it means nobody can quote your number except your insurer.
Coverage, and where it stops
Midi names Aetna, Blue Cross Blue Shield, Cigna, Health Net and UnitedHealthcare as insurance partners and states it is in-network with most PPO plans. The exclusions are stated just as plainly: Medicare is out of network, and Midi is not able to accept Medicaid or Medi-Cal patients. HSA and FSA funds can be used for visits and services.
Two gaps follow from that, and both hit exactly the populations menopause care most often fails. Anyone on Medicare is outside the network, whether enrolled by age or by disability. Women on Medicaid cannot be seen at all. For both groups, the self-pay rate of $250 and $150 is the only available price, which is a real cost for care that a traditional in-network gynecologist might cover.
Clinicians and clinical approach
Midi's clinicians are board-certified nurse practitioners, certified nurse midwives, physicians and naturopathic doctors specializing in women's midlife health. Several hold Menopause Society certification, and Midi publishes individual clinician profiles listing those credentials. Midi states its protocols are evidence-based and informed by current literature and guidelines from ACOG, the AMA, ISSWSH, The Menopause Society, the NCCN and The Obesity Association.
Naming the NCCN alongside the menopause bodies is not decorative. Cancer survivorship is one of the harder problems in this field, because a history of estrogen-sensitive cancer changes which options are on the table, and it is a conversation many general practices avoid entirely. A practice that cites oncology guidance is signaling that it intends to have that conversation rather than decline it. Whether any individual clinician is the right one for a complex history is still a question to ask directly at the first visit.
Company-reported results
Midi's homepage states it has cared for more than 500,000 women (its own pages give differing totals) and reports that 95% of patients report peri/menopause symptom improvement after at least two months. Both figures are company-reported rather than independently audited, and the second has no published denominator, follow-up period or definition of improvement attached. Treat it as a marketing claim, not as trial data. The evidence that matters for your decision is the underlying literature on hormone therapy, which is independent of any platform.
Public litigation
As of October 2026, two federal civil suits against Midi Health, Inc. have closed. Both were filed in the U.S. District Court for the Northern District of California and ended without a ruling on the merits. In N.C. v. Midi Health, Inc. (No. 5:25-cv-02848, filed March 26, 2025), the plaintiffs filed a notice of voluntary dismissal on September 24, 2025, and the court terminated the case the following day. In Baker v. Midi Health, Inc. (No. 5:25-cv-10414, filed December 4, 2025), the docket records a filing labelled "Compel" on March 23, 2026, followed by a notice of voluntary dismissal and termination on March 27, 2026.
A voluntary dismissal is not a finding for or against either party. A CourtListener federal docket search as of October 2026 returned no other civil cases naming Midi Health as a defendant. In addition, web searches found no Food and Drug Administration (FDA) warning letters, Federal Trade Commission (FTC) actions, or state medical-board enforcement proceedings against Midi Health. A web search can miss records, so this does not prove none exist.
Midi Health's published Terms and Conditions include a binding arbitration clause. Disputes are resolved through individual arbitration, with waivers of jury trials and class actions unless a patient timely opts out.
Strengths
- Insurance actually pays for the visit. In-network status with most PPO plans, including five named national insurers, moves the largest controllable line onto the plan.
- Diagnosis is on the table, not just prescription. Thyroid, metabolic and insulin-sensitivity testing can be ordered when the picture is unclear.
- A real appointment. Thirty minutes of clinician time allows a history and a contraindication discussion that no intake form replaces.
- Specialist credentials, published. Menopause Society certification is held by multiple clinicians and listed on individual profiles.
- Nationwide, with no subscription. All 50 states, pay per visit, most prescriptions to the pharmacy of your choice.
Trade-offs
- Your price is unknowable in advance. Deductible, coinsurance and copay decide it, and none of them are visible at booking.
- Medicare and Medicaid are excluded. Two of the populations most likely to need affordable menopause care are outside the model.
- Three separate bills. Visit, labs and pharmacy arrive from different places at different times.
- Testing is discretionary. Labs are ordered when indicated, so a woman who wants a defined baseline panel has to ask for it rather than expect it.
- Two civil suits, both voluntarily dismissed. Neither reached a decision on the merits; the published terms contain an arbitration notice and class-action waiver.
How it compares
Menopause-specialist platforms, listed alphabetically. Ordering carries no editorial meaning.
| Platform | Model | Price | Insurance | Labs |
|---|---|---|---|---|
| Alloy | Asynchronous prescribing with its own pharmacy | $49 one-time consult, then published per-product medication prices | Cash-pay only; HSA and FSA eligible | No lab panel in the standard path |
| Evernow | Menopause telehealth, hormonal and non-hormonal | Subscription plus medication | Direct-pay | Varies by plan |
| Midi Health | Virtual clinical practice billing insurance | $250 first visit, $150 returning visit self-pay | In-network with most PPO plans | Labs ordered when indicated, billed separately |
| Winona | Menopause telehealth, prescription-led | ~$30–$100/mo plus medication | Direct-pay | Varies by plan |
The split in this category is not really about price, it is about which half of the bill each platform optimizes. Cash-pay services set the medication price and charge little to be seen. Midi sets the visit price, or lets your insurer set it, and leaves the medication to your pharmacy. Compare a full year of both halves, not the headline number, and check your pharmacy benefit before deciding either way. Winona vs Midi Health sets a flat monthly cash rate against per-visit insurance billing.
Who should buy it, and who should not
Buy it if you have a PPO plan and unexplained midlife symptoms. Fatigue, weight change, poor sleep and brain fog overlap almost completely with thyroid disease and iron deficiency, both of which are common in this age group and both of which get missed when a platform only prescribes. A clinician who can order the test and read it against the hormone question is worth the visit fee even if the answer turns out to be hormonal after all.
Skip it if you are uninsured, on Medicare or Medicaid, or have already made the decision. If you know you want a transdermal estradiol patch and micronized progesterone, and your thyroid and iron picture is current and normal, you are paying for a diagnostic conversation you do not need. A cash-pay prescribing route reaches the same prescription faster and at a price you can see up front.
Before your first visit
Four things make the appointment more useful. Run your insurance through the coverage check on Midi's site rather than assuming, since plan type matters more than insurer name. Bring your last lab results if you have any, so the clinician is not starting from zero. Write down your cycle history, including dates, because perimenopause is diagnosed clinically from that pattern rather than from a single hormone value. And list every medication and supplement you take, since several interact with hormone therapy.
Ask two questions at the visit. Which labs are you ordering, and is each one covered by my plan. And which specific product and delivery route are you proposing, since a patch, a gel and an oral tablet differ in cost and in clotting risk. Neither question is confrontational, and both prevent the bills that arrive later.
Frequently Asked Questions
What is Midi Health?
Midi Health is a virtual clinical practice for women in perimenopause and menopause, available in all 50 states. Clinicians take a history over a 30-minute first visit, build a care plan, and prescribe hormonal or non-hormonal treatment, sent to your pharmacy or, for some compounded products, to the compounding pharmacy named in Midi's terms. It differs from most menopause telehealth in that it bills insurance rather than operating as a cash-pay subscription, and it can order labs when the symptom picture calls for them.
How much does Midi Health cost?
Self-pay pricing is published at $250 for a first visit and $150 for a returning visit, with no membership or subscription fee. If you use in-network insurance, the visit is billed to your plan and your share depends on your deductible, coinsurance and copay. Labs and prescriptions are separate: labs are billed when ordered, and most medication is filled by your pharmacy at whatever your benefit charges (compounded products can come from the compounding pharmacy named in Midi's terms).
Which insurance does Midi Health accept?
Midi states it is in-network with most PPO plans and names Aetna, Blue Cross Blue Shield, Cigna, Health Net and UnitedHealthcare as partners. Medicare is out of network, and Midi does not accept Medicaid or Medi-Cal patients. Coverage still varies by specific plan, so run your details through the coverage check on Midi's own site rather than assuming your insurer's presence on the list settles it. HSA and FSA funds can be used for visits and services.
Who are Midi Health clinicians?
Midi's clinicians are board-certified nurse practitioners, certified nurse midwives, physicians and naturopathic doctors who specialize in midlife women's health, and several hold certification from The Menopause Society. Midi states its protocols are informed by guidance from ACOG, the AMA, ISSWSH, The Menopause Society, the NCCN and The Obesity Association. Individual clinician credentials are listed on Midi's own clinician pages.
Does Midi Health order bloodwork?
Yes, when indicated rather than as a standard panel. Midi names a metabolic panel, thyroid testing and insulin-sensitivity markers among the tests it may order, and generally uses Labcorp because of its drop-in network, though it can order elsewhere on request. Labs are billed separately from the visit. This is the main thing that separates Midi from asynchronous prescribing services, which typically run no labs at all.
What can Midi Health prescribe?
Midi lists hormone prescriptions including HRT patches, estradiol cream, vaginal estrogen and progesterone, along with non-hormone prescriptions and GLP-1 medications. Some products are available after a short asynchronous visit while others require a full visit. Most prescriptions are sent to your pharmacy (Midi's terms also name a compounding pharmacy for some products), so the medication cost runs through your pharmacy benefit rather than through Midi.
Is Midi Health available in my state?
Midi states it is available in all 50 states, with insurance coverage for virtual visits and prescriptions. Whether your specific plan is in-network is a separate question from whether the service operates in your state, and the two are easy to conflate. Check both before booking.
Has Midi Health been sued?
Yes. As of October 2026, two federal civil suits have been filed against Midi Health, Inc. in the U.S. District Court for the Northern District of California. Plaintiffs filed N.C. v. Midi Health in March 2025 and Baker v. Midi Health in December 2025. Both were voluntarily dismissed by the plaintiffs, ending in September 2025 and March 2026. Neither case reached a decision on the merits. A voluntary dismissal is not a finding for or against either party. In addition, Midi's published terms require resolving disputes through binding individual arbitration unless you timely opt out.
Is Midi Health worth it?
It is worth it when insurance carries the visit and your symptoms are not yet explained, because those are the two conditions the model is built for. It is a weaker fit if you have already settled on a specific hormone product and simply want it prescribed and shipped, since a cash-pay prescribing service does that in less time for a known price. Run your plan through the coverage check first; the answer to that question decides most of this one.